Xenopus laevis tadpoles were held in 4 replicate vivaria for each of 4 treatments of neonicotinoid pesticides and one control treatment for at least one month (Control media, thiamethoxam high concentration of 100 ppm, thiamethoxam low concentrations of 20 ppm, clothianidin high concentrations of 100 ppm, and clothianidin low concentration of 20 ppm). Water was sampled for chemical testing on Day 33. Between Day 1 and 44, instantaneous measures of length were collected on a random selection of tadpoles from each vivarium. On Day 44, tadpole length (mm), weight, and developmental stage (Nieuwkoop-Faber staging) were measured for all tadpoles in all vivaria (three of the measured individuals from each replicate treatment group (total n=12 for each treatment) were vivisected and liver, brain, and somatic tissue frozen in RNA/DNA shield for qPCR analyses for another study). On Day 44, tadpoles (n=5) which had reached NF stage 57 were transferred to other vivaria and remained in their original treatment solution through Day 76; these animals were monitored until metamorphosis.
Citation Information
Publication Year | 2021 |
---|---|
Title | Xenopus metamorphosis after neonicotinoid exposure |
DOI | 10.5066/P97PROVJ |
Authors | Jill Jenkins, Bonnie L Brown |
Product Type | Data Release |
Record Source | USGS Digital Object Identifier Catalog |
USGS Organization | Wetland and Aquatic Research Center |
Related Content
Juvenile African clawed frogs (Xenopus laevis) express growth, metamorphosis, mortality, gene expression, and metabolic changes when exposed to thiamethoxam and clothianidin
Related Content
- Publications
Juvenile African clawed frogs (Xenopus laevis) express growth, metamorphosis, mortality, gene expression, and metabolic changes when exposed to thiamethoxam and clothianidin
Neonicotinoids (NEO) represent the main class of insecticides currently in use, with thiamethoxam (THX) and clothianidin (CLO) primarily applied agriculturally. With few comprehensive studies having been performed with non-target amphibians, the aim was to investigate potential biomarker responses along an adverse outcome pathway of NEO exposure, whereby data were collected on multiple biologicalAuthorsJill Jenkins, Katherine R. Hartop, Ghadeer Bukhari, Debra E. Howton, Kelly Smalling, Scott Mize, Michelle Hladik, Darren Johnson, Rassa Dale, Bonnie L. Brown